EPAM
BIO icon

Evelyn Partners Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Evelyn Partners Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.53K Hold
27
– – ﹤0.01% 273
2025
Q4 		$8.18K Hold
27
– – ﹤0.01% 249
2025
Q3 		$7.57K Hold
27
– – ﹤0.01% 244
2025
Q2 		$6.52K Hold
27
– – ﹤0.01% 210
2025
Q1 		$6.58K Hold
27
– – ﹤0.01% 212
2024
Q4 		$8.87K Buy
+27
New +$9.16K ﹤0.01% 205

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Evelyn Partners Asset Management's BIO Position: Q1 2026 in Review

Evelyn Partners Asset Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q1 2026 at 27 shares worth $7.53K. The position accounts for ﹤0.01% of the portfolio, ranked #273.

Evelyn Partners Asset Management first reported a position in BIO in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.87K in Q4 2024. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Evelyn Partners Asset Management held 27 shares of Bio-Rad Laboratories Class A worth $7.53K as of Q1 2026.
  • Evelyn Partners Asset Management left its Bio-Rad Laboratories Class A share count unchanged in Q1 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Evelyn Partners Asset Management's portfolio in Q1 2026, its #273 holding.
  • Evelyn Partners Asset Management first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Asset Management's Bio-Rad Laboratories Class A position peaked at $8.87K in Q4 2024.
  • 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Evelyn Partners Asset Management's 13F filing for Q1 2026, filed 15 May 2026.